(Q37810968)

23 August 2017

Adult T-cell leukemia-lymphoma: current treatment strategies and novel immunological approaches (English)

1 reference

23 August 2017

1 reference

1 reference

Ryuji Tanosaki

1

1 reference

PubMed ID

21091150

23 August 2017

Kensei Tobinai

series ordinal

2

1 reference

PubMed ID

21091150

23 August 2017

language of work or name

1 reference

1 December 2010

1 reference

Expert Review of Hematology

23 August 2017

1 reference

23 August 2017

3

1 reference

23 August 2017

743-753

1 reference

23 August 2017

6

1 reference

Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation

23 August 2017

1 reference

Natural history of adult T-cell leukemia/lymphoma and approaches to therapy

21 January 2018

1 reference

Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting

21 January 2018

1 reference

Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87).

21 January 2018

1 reference

Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine

21 January 2018

1 reference

Long-term study of indolent adult T-cell leukemia-lymphoma

21 January 2018

1 reference

Clinical trials for human T-cell lymphotropic virus type I-associated peripheral T-cell lymphoma in Japan

21 January 2018

1 reference

Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study (JCOG9109).

21 January 2018

1 reference

A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303.

21 January 2018

1 reference

VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801.

21 January 2018

1 reference

Poor outcome of autologous stem cell transplantation for adult T cell leukemia/lymphoma: a case report and review of the literature

21 January 2018

1 reference

Infection of donor lymphocytes with human T lymphotrophic virus type 1 (HTLV-I) following allogeneic bone marrow transplantation for HTLV-I positive adult T-cell leukaemia

21 January 2018

1 reference

Successful treatment of HTLV-1-associated acute adult T-cell leukaemia lymphoma by allogeneic bone marrow transplantation.

21 January 2018

1 reference

Eradication of human T-lymphotropic virus type 1 by allogeneic bone-marrow transplantation

21 January 2018

1 reference

Allogeneic stem cell transplantation for adult T-cell leukemia/lymphoma

21 January 2018

1 reference

Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma

21 January 2018

1 reference

Allogeneic bone marrow transplantation from unrelated human T-cell leukemia virus-I-negative donors for adult T-cell leukemia/lymphoma: retrospective analysis of data from the Japan Marrow Donor Program

21 January 2018

1 reference

Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study.

21 January 2018

1 reference

Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma

21 January 2018

1 reference

Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia/lymphoma: impact of antithymocyte globulin on clinical outcome

21 January 2018

1 reference

Bortezomib therapy in patients with relapsed or refractory lymphoma: potential correlation of in vitro sensitivity and tumor necrosis factor alpha response with clinical activity

21 January 2018

1 reference

Adult T-cell leukaemia/lymphoma

21 January 2018

1 reference

Denileukin diftitox and hyper-CVAD in the treatment of human T-cell lymphotropic virus 1-associated acute T-cell leukemia/lymphoma

21 January 2018

1 reference

Complete response in a patient with adult T-cell leukemia (ATL) treated with combination of alemtuzumab and pentostatin

21 January 2018

1 reference

Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-{alpha}-refractory adult T-cell leukemia

21 January 2018

1 reference

Recent advances in adult T-cell leukemia therapy: focus on a new anti-transferrin receptor monoclonal antibody

21 January 2018

1 reference

Eradication of virus-infected T-cells in a case of adult T-cell leukemia/lymphoma by nonmyeloablative peripheral blood stem cell transplantation with conditioning consisting of low-dose total body irradiation and pentostatin

21 January 2018

1 reference

Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease

21 January 2018

1 reference

Tumor immunity against adult T-cell leukemia

21 January 2018

1 reference

Potential immunogenicity of adult T cell leukemia cells in vivo.

21 January 2018

1 reference

Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan

21 January 2018

1 reference

Treatment of Adult T-Cell Leukemia-Lymphoma with Zidovudine and Interferon Alfa

21 January 2018

1 reference

Meta-Analysis on the Use of Zidovudine and Interferon-Alfa in Adult T-Cell Leukemia/Lymphoma Showing Improved Survival in the Leukemic Subtypes

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/EHM.10.73

1 reference

23 August 2017

1 reference

PubMed ID

21091150